Company intelligence / Profile preview
NeuroGenesis
Jerusalem, Israelpmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NeuroGenesis Bio Inc. develops autologous bone marrow-derived stem cell therapies targeting remyelination, neuroprotection, and regeneration for neurodegenerative diseases. Its lead asset, NG‑01—delivered intrathecally—has shown positive safety/tolerability results with promising efficacy signals in reducing key biomarkers of disease progression and improving physical/cognitive outcomes in progressive multiple sclerosis. The company has also demonstrated encouraging results from two successful Phase IIa studies in ALS patients. A global multi-center Phase IIb trial for progressive MS was FDA-cleared as of March 2024.
- Therapeutic areas
- Neurology
- Modalities
- Autologous cell therapystem cells (bone marrow-derived)regenerative medicine
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with leading hospitals worldwide for clinical trialsHadassah Medical Center Jerusalem principal investigator site.
Beyond the preview
Go deeper on NeuroGenesis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeuroGenesis.